Gerdnil is a proton pump inhibitor used to reduce excessive stomach acid production and manage a variety of acid-related gastrointestinal disorders. It is commonly prescribed for the treatment of gastroesophageal reflux disease, gastric and duodenal ulcers, erosive esophagitis, and chronic acid reflux symptoms. By suppressing gastric acid secretion, Gerdnil helps relieve heartburn, acid regurgitation, upper abdominal discomfort, and irritation of the esophageal lining while promoting healing of damaged gastrointestinal tissues. This medicine is widely used in the long-term management of acid-peptic conditions and provides effective gastric protection in patients requiring controlled acid suppression therapy under professional medical care.